Company news

Mayne Pharma Group Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Mayne Pharma receives FDA approval for Doryx MPC tablets

May 23, 2016

2015 Appendix 4E & Annual Report

February 11, 2016

US Sales of Doryx Update

February 10, 2016

US Oxycodone franchise restructure and Doryx re-launch

February 10, 2016

US Court decides on Doryx 161 Patent

February 10, 2016

Successful Phase II SUBACAP trial

February 10, 2016

Successful EU SUBA Clinical Study

February 10, 2016

SUBACAP Update

February 10, 2016

Singapore Distribution Agreement Signed

February 10, 2016

Retail Offer Booklet

February 10, 2016

Preliminary Final Report and Maiden Dividend

February 10, 2016

Pfizer withdraws US Tikosyn Litigation against Mayne Pharma

February 10, 2016

New equity investment in Hedgepath Pharmaceuticals

February 10, 2016

MYX appoints scott richards as CEO

February 10, 2016

MYX announces US agreement for Itraconazole in Cancer

February 10, 2016

Media Speculation

February 10, 2016

Mayne Pharma successfully completes US$125m debt financing

February 10, 2016

Mayne Pharma Signs European SUBACAP Distribution Agreements

February 10, 2016

Mayne Pharma results and product update

February 10, 2016

Mayne Pharma recipient of A$4m Government Grant

February 10, 2016

Mayne Pharma out-licenses IP to Hedgepath Pharmaceuticals

February 10, 2016

Mayne Pharma Market Update

February 10, 2016

Mayne Pharma Launches Generic Doryx

February 10, 2016

Mayne Pharma announces US Paragraph IV Challenge

February 10, 2016

Mayne Pharma Announces the Acquisition of Metrics, Inc.

February 10, 2016

Mayne Pharma announces the acquisition of Kapanol

February 10, 2016

Mayne Pharma announces SUBACAP approvable

February 10, 2016

Mayne Pharma announces in-licensing agreement

February 10, 2016

Mayne Pharma announces acquisition of LORCET & ESGIC

February 10, 2016

Mayne Pharma announces acquisition of Libertas

February 10, 2016

Mayne Pharma announces acquisition of Doryx

February 10, 2016

Mayne announces strategic investment in US facilities

February 10, 2016

Half Year Results and Accounts

February 10, 2016

Future Cash Flow Reporting

February 10, 2016

FDA Approval Of New Dual-Scored 150mg Doryx Tablet

February 10, 2016

FDA Approval of New 200mg Doryx Tablet

February 10, 2016

Doryx Generic Update

February 10, 2016

Director resignation and management update

February 10, 2016

Completion of US Phase II Study Recruitment

February 10, 2016

Completion of placement

February 10, 2016

Completion institutional entitlement/unconditional placement

February 10, 2016

Chairman`s Address to Shareholders

February 10, 2016

Appendix 4C - quarterly

February 10, 2016

2014 Appendix 4E & Annual Report

February 10, 2016

2013 Half Year Media Release

February 10, 2016

2013 Full Year Results Appendix 4E

February 10, 2016

2012 AGM CEOs Speech

February 10, 2016

← Newer news releases

Calls

Decks

The 5 newest of 90 decks. Every deck is listed under its year.